Authors: Landry, ML Stanat, S Biron, K Brambilla, D Britt, W Jokela, J Chou, SW Drew, WL Erice, A Gilliam, B Lurain, N Manischewitz, J Miner, R Nokta, M Reichelderfer, P Spector, S Weinberg, A Yen-Lieberman, B Crumpacker, C

Citation: Ml. Landry et al., A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates, ANTIM AG CH, 44(3), 2000, pp. 688-692

Authors: Mach, M Kropff, B Dal Monte, P Britt, W

Citation: M. Mach et al., Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N(gpUL73), J VIROLOGY, 74(24), 2000, pp. 11881-11892

Authors: Pass, RF Duliege, AM Boppana, S Sekulovich, R Percell, S Britt, W Burke, RL

Citation: Rf. Pass et al., A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant, J INFEC DIS, 180(4), 1999, pp. 970-975

Authors: Sun, Q Pollok, KE Burton, RL Dai, LJ Britt, W Emanuel, DJ Lucas, KG

Citation: Q. Sun et al., Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65, BLOOD, 94(9), 1999, pp. 3242-3250